1,091
Views
34
CrossRef citations to date
0
Altmetric
Reviews

Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads

, PhD (Research Investigator III) & , PhD (Senior Research Investigator II)
Pages 1095-1107 | Published online: 07 Oct 2010

Bibliography

  • Mayr LM, Furst P. The future of high-throughput screening. J Biomol Screen 2008;13(6):443-8
  • Thorne N, Auld DS, Inglese J. Apparent activity in high-throughput screening: origins of compound- dependent assay interference. Curr Opin Chem Biol 2010;14:1-10
  • Shiau K, Massari M, Ozbal CC. Back to basics: label-free technologies for small molecule screening. Comb Chem High Throughput Screen 2008;11:231-7
  • Zhu Z, Cuozzo J. High-throughput affinity-based technologies for small-molecule drug discovery. J Biomol Screen 2009;14:1157-64
  • Whitehurst CE, Nazeef N, Annis DE, Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectroscopy. J Biomol Screen 2006;11:194-207
  • Annis DA, Cheng CC, Chuang CC, Inhibitors of the lipid phosphatase SHIP2 discovered by high-throughput affinity selection-mass spectrometry screening of combinatorial libraries. Comb Chem High Throughput Screen 2009;12(8):760-71
  • Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315-17
  • Smith GP, Petrenko VA. Phage display. Chem Rev 1997;97(2):391-4107
  • Brenner S, Lerner RA. Encoded combinatorial chemistry. PNAS 1992;89(12):5381-3
  • Melkko S, Dumelin CE, Scheuermann J, Neri D. Lead discovery by DNA-encoded chemical libraries. Drug Discov Today 2007;12(11-12):465-71
  • Clark MA, Acharya RA, Arico-Muendel C, Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat Chem Biol 2009;5(9):647-54
  • Scheuermann J, Neri D. DNA-encoded chemical libraries: a tool for drug discovery and for chemical biology. ChemBioChem 2010;11(7):931-7
  • Kinoshita Y, Nishigaki K. Enzymatic synthesis of code regions for encoded combinatorial chemistry (ECC). Nucleic Acids Symp Ser 1995;34:201-2
  • Clark MA. Selecting chemicals: the emerging utility of DNA-encoded libraries. Curr Opin Chem Biol 2010;14(3):396-403
  • Margulies M, Egholm WE, Altman S, Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005;437:376-80
  • Mannocci L, Zhang Y, Scheuermann J, High-throughput sequencing allows the identification of binding molecules isolated from DNA-encoded chemical libraries. PNAS 2008;105:17670-5
  • Available from: www.nuevolution.com
  • Available from: www.philochem.ch
  • Available from: www.vipergen.com
  • Buller F, Zhang Y, Scheuermann J, Discovery of TNF inhibitors from a DNA-encoded chemical library based on diels-alder cycloaddition. Chem Biol 2009;16(10):1075-86
  • Melkko S, Mannocci L, Dumelin CE, Isolation of a small-molecule inhibitor of the antiapoptotic protein Bcl-xL from a DNA-encoded chemical library. ChemMedChem 2010;5(4):584-90
  • Greis KD. Mass spectrometry for enzyme assays and inhibitor screening: an emerging application in pharmaceutical research. Mass Spectrom Rev 2007;26(3):324-39
  • Zehender H, Le Goff F, Lehmann N, SpeedScreen: the “missing link” between genomics and lead discovery. J Biomol Screen 2004;9(6):498-505
  • Annis DA, Athanasopoulos J, Curran PJ, An affinity selection–mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries: discovery of a novel antagonist of E. coli dihydrofolate reductase. Int J Mass Spectrom 2004;238(2):77-83
  • Comess KM, Schurdak ME, Voorbach MJ, An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurF. J Biomol Screen 2006;11(7):743-54
  • Jonker N, Kretschmer A, Kool J, Online magnetic bead dynamic protein-affinity selection coupled to LC-MS for the screening of pharmacologically active compounds. Anal Chem 2009;81(11):4263-70
  • Coburn CA, Stachel SJ, Li YM, Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases. J Med Chem 2004;47(25):6117-19
  • Comess KM, Trumbull JD, Park C, Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1. J Biomol Screen 2006;11(7):755-64
  • Hofner G, Merkel D, Wanner KT. MS binding assays – with MALDI toward high throughput. ChemMedChem 2009;4:1523-8
  • Cooper M. Label-free screening of bio-molecular interactions. Anal Bioanal Chem 2003;377:834-42
  • Comley J. Label-free detection: new biosensors facilitate broader range of drug discovery applications. Drug Discov World 2005; Winter 2004/5:63-74
  • Lofas S. Optimizing the hit-to-lead process using SPR analysis. Assay Drug Dev Technol 2004;2(4):407-15
  • Perspicace S, Banner D, Benz J, Fragment-based screening using surface plasmon resonance technology. J Biomol Screen 2009;14(4):337-49
  • Neumann T, Junker HD, Schmidt K, SPR-based fragment screening: advantages and applications. Curr Top Med Chem 2007;7(16):1630-42
  • Englebienne P, Van Hoonacker A, Verhas M, Advances in high-throuput screening: biomolecular interaction monitoring in real-time with colloidal metal nanoparticles. Comb Chem High Throughput Screen 2003;6:777-87
  • Available from: www.pharmadiagnostics.com
  • Available from: www.corning.com/lifesciences
  • Available from: www.srubiosystems.com
  • Available from: www.fortebio.com
  • Cunningham BT, Laing L. Microplate-based, label-free detection of biomolecular interactions: applications in proteomics. Expert Rev Proteomics 2006;3(3):271-81
  • O'Malley SM, Xie X, Frutos AG. Label-free high-throughput functional lytic assays. J Biomol Screen 2007;12:117-25
  • Concepcion J, Witte K, Wartchow C, Label-free detection of biomolecular interactions using biolayer interferometry for kinetic characterization. Comb Chem High Throughput Screen 2009;12(8):791-800
  • Ng ES, Chan NW, Lewis DF, Frontal affinity chromatography – mass spectrometry. Nat Protoc 2007;2(9):1907-17
  • Ng W, Dai JR, Slon-Usakiewicz JJ, Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS). J Biomol Screen 2007;12(2):167-74
  • Calleri E. Frontal affinity chromatography – mass spectrometry useful for characterization of new ligands for GPR17 receptor. J Med Chem 2010;53(9):3489-501
  • Zhang J, Adrian FJ, Jahnke W, Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature 2010;463:501-6
  • Graf C, Stankiewicz M, Nikolay R, Insights into the conformational dynamics of the E3 ubiquitin ligase CHIP in complex with chaperones and E2 enzymes. Biochemistry 2010;49(10):2121-9
  • Coan KE, Maltby DA, Burlingame AL, Shoichet BK. Promiscuous aggregate-based inhibitors promote enzyme unfolding. J Med Chem 2009;52(7):2067-75
  • Hopper ED, Roulhac PL, Campa MJ, Throughput and efficiency of a mass spectrometry-based screening assay for protein-ligand binding detection. J Am Soc Mass Spectrom 2008;19(9):1303-11
  • McCullough BJ, Gaskell SJ. Using electrospray ionisation mass spectrometry to study non-covalent interactions. Comb Chem High Throughput Screen 2009;12(2):203-11
  • Bovet C, Wortmann A, Eiler S, Estrogen receptor-ligand complexes measured by chip-based nanoelectrospray mass spectrometry: an approach for the screening of endocrine disruptors. Protein Sci 2007;16(5):938-46
  • Benkestock K, Van Pelt CK, Akerud T, Automated nano-electrospray mass spectrometry for protein-ligand screening by noncovalent interaction applied to human H-FABP and A-FABP. J Biomol Screen 2003;8(3):247-56
  • Senisterra GA, Finerty PJ. High throughput methods of assessing protein stability and aggregation. Mol BioSyst 2009;5:217-23
  • Leung SM, Senisterra G, Ritchie KP, Thermal activation of the bovine Hsc70 molecular chaperone at physiological temperatures: physical evidence of a molecular thermometer. Cell Stress Chaperones 1996;1(1):78-9
  • Nielsen FH, Berglund H, Vedadi M. The use of differntial scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2007;2(9):2212-21
  • Pantoliano MW, Rhind AW, Salemme FR. Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization. US6020141; 2000
  • Carver TE, Bordeau B, Cummings MD, Decrypting the biochemical function of an essential gene from Streptococcus pneumoniae using ThermoFluor technology. J Biol Chem 2005;280(12):11704-12
  • Grasberger BL, Lu T, Schubert C, Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. J Med Chem 2005;48(4):909-12
  • Matulis D, Kranz JK, Salemme FR, Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry 2005;44(13):5258-66
  • Zubriene A, Matuliene J, Baranauskiene L, Measurement of nanomolar dissociation constants by titration calorimetry and thermal shift assay – radicicol binding to Hsp90 and ethoxzolamide binding to CAII. Int J Mol Sci 2009;10(6):2662-80
  • Senisterra GA, Markin E, Yamazaki K, Screening for ligands using a generic and high-throughput light scattering based assay. J Biomol Screen 2006;11(8):940-8
  • Available from: www.harbingerbiotech.com
  • Vedadi M, Niesen FH, Allali-Hassani A, Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. PNAS 2006;103(43):15835-40
  • Available from: www.anadyspharma.com
  • Thompson PA, Wang S, Howett LJ, Identification of ligand binding by protein stabilization: comparison of ATLAS with biophysical and enzymatic methods. Assay Drug Dev Technol 2008;6(1):69-81
  • Patel R, LeBrun LA, Howett LJ, ATLAS-A high-throughput affinity-based screening technology for soluble proteins: technology apllication using p38 MAP kinase. Assay Drug Dev Technol 2008;6(1):55-68
  • Baugh C, Wang S, Li B, SCAN–a high-throughput assay for detecting small molecule binding to RNA targets. J Biomol Screen 2009;14(3):219-29
  • Jahnke W, Widmer H. Protein NMR in biomedical research. Cell Mol Life Sci 2004;61(5):580-99
  • Pellecchia M, Bertini I, Cowburn D, Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov 2008;7(9):738-45
  • Schade M. NMR fragment screening: advantages and applications. Idrugs 2006;9(2):110-13
  • Powers R. Advances in nuclear magnetic resonance for drug discovery. Expert Opin Drug Discov 2009;4(10):1077-98
  • Murray CW, Carr MG, Callaghan O, Fragment-based drug discovery applied to hsp90. Discovery of two lead series with high ligand efficiency. J Med Chem 2010;53(16):5942-55
  • Cross G, Reeves A, Brand S, A new quantitative optical biosensor for protein characterisation. Biosen Bioelectron 2003;19(4):383-90
  • Swann M, Peel L, Carrington S, Dual-polarization interferometry: an analytical technique to measure changes in protein structure in real time, to determine the stoichiometry of binding events, and to differentiate between specific and nonspecific interactions. Anal Biochem 2004;329:190-8
  • Bornhop DJ, Latham JC, Kussrow A, Free-solution, label-free molecular interactions studied by back-scattering interferometry. Science 2007;317:1732-6
  • Kussrow A, Enders CS, Morcos EF, Backscattering interferometry or low sample consumption molecular interaction screening. JALA 2009;14(6):341-7
  • Latham JC, Stein JC, Richard A, Free-solution label-free detection of alpha -crystallin chaperone interactions by back-scattering interferometry. Anal Chem 2009;81(5):1865-71
  • Available from: www.molecularsensing.com

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.